Avoid common mistakes on your manuscript.
A 28-year-old female with Scheuermann disease presented to the rheumatology and chronic pain clinics for follow-up. She is known with fibromyalgia and hypermobility, presenting as widespread chronic pain and joint laxity, bladder pain syndrome, irritable bowel syndrome, and depression. She had a longstanding history of severe abdominal pain since menarche at 13 years of age, which was eventually diagnosed as endometriosis. The patient used hot water bottles extensively on her abdomen to alleviate the pain, resulting in striking abdominal erythema ab igne that was noted at the time of laparoscopic ablation of the endometriosis at 23 years of age (Fig. 1A). A sacral neuromodulator device was also implanted for the bladder pain syndrome, resulting in the abdominal pain improving significantly. She did not use hot water bottles since the combined management approach, but the characteristic reticular hyperpigmentation pattern—although improved—was permanent 5 years later at follow-up presentations (Fig. 1B). The patient was however concerned about further skin changes over the areas of discolouration, in particular the possibility of malignancy. She was counselled and referred to a multidisciplinary team for dermatological follow-up.
The hyperpigmentation of erythema ab igne is predominantly caused by epidermal atrophy and hemosiderin or melanin deposition due to infrared radiation from an external heat source [1]. With ongoing exposure, focal dyskeratosis with squamous atypia may present, increasing malignant transformation risk [2]. As such, longstanding or permanent erythema ab igne, as in this case, predisposes to the development of squamous cell carcinoma over the areas of hyperpigmentation [2]. As these patients are often kept under the care of a rheumatologist for primary pain conditions, they should be counselled and followed up periodically to monitor for any skin changes over the area. This includes Marjolin ulcers, which are aggressive squamous cell carcinomas arising from previous scar tissue or chronically inflamed tissue [3]. Younger patients also appear to have an increased risk, as a Swedish registry study showed that the standardized incidence rate for squamous cell carcinoma in rheumatoid arthritis patients < 50 years old was 2.37 (95% confidence interval [CI] 1.46 to 3.62) compared to 1.89 (95% CI 1.68 to 2.12) for all age groups [4]. A vigilant index of suspicion should be maintained especially in younger rheumatological patients with an area of longstanding erythema ab igne, and if any skin changes are noted, biopsy and/or prompt dermatology referral is warranted.
References
Abasszade JH, Abrahams T, Kuan CC et al (2023) Erythema ab igne. BMJ Case Rep 16:e255308. https://doi.org/10.1136/bcr-2023-255308
Wipf AJ, Brown MR (2022) Malignant transformation of erythema ab igne. JAAD Case Rep 26:85–87. https://doi.org/10.1016/j.jdcr.2022.06.018
Bazaliński D, Przybek-Mita J, Barańska B et al (2017) Marjolin’s ulcer in chronic wounds–review of available literature. Contemp Oncol 21(3):197–202. https://doi.org/10.5114/wo.2017.70109
Hemminki K, Li X, Sundquist K et al (2008) Cancer risk in hospitalized rheumatoid arthritis patients. Rheumatology 47(5):698–701. https://doi.org/10.1093/rheumatology/ken130
Acknowledgements
None.
Funding
Open access funding provided by Stellenbosch University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
van Rensburg, R., Reuter, H. Abdominal erythema ab igne—beyond the rash. Clin Rheumatol (2024). https://doi.org/10.1007/s10067-024-06998-1
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10067-024-06998-1